Current Topics of Progressive Cardiac Conduction Disease

Area of Science:

• Cardiology
• Genetics
• Medical Genetics

Background:

• Progressive cardiac conduction disease (PCCD) is a rare inheritable condition affecting the heart's electrical system.
• It can lead to severe outcomes like complete heart block, syncope, and sudden cardiac death.
• The estimated incidence of PCCD is 0.0005% per year.

Purpose of the Study:

• To provide a clinically relevant overview of PCCD.
• To emphasize the genetic basis and phenotypic expression of various PCCD forms.
• To propose a practical classification for diagnosis, risk stratification, and patient management.

Main Methods:

• This is a review article, synthesizing existing research on PCCD.
• It focuses on genetic associations, including ion channel, gap junction, myopathy, transcription factor, metabolic, and mitochondrial genes.
• Clinical implications for diagnosis and management are discussed.

Main Results:

• Numerous genes have been linked to PCCD development, including SCN5A, LMNA, NKX2-5, and PRKAG2.
• PCCD presents with diverse genetic underpinnings and phenotypic expressions.
• Pacemaker implantation is the primary treatment, with implantable cardioverter defibrillators considered for specific cases.

Conclusions:

• Understanding the genetic basis of PCCD is crucial for accurate diagnosis and risk stratification.
• A proposed classification system can aid in managing isolated and associated forms of PCCD.
• Further research into genetic variants and their clinical impact will refine patient management strategies.